Latest Government Incentives News

Sunshine Metals reported significant progress in north Queensland with high-grade gold intersections at Liontown and Sybil, alongside a $1.225 million acquisition and government grants to accelerate exploration.

Galan Lithium has locked in a $20 million strategic placement and secured a key Argentine government incentive, positioning its Hombre Muerto West project for production in early 2026.

Platina Resources reported steady progress across multiple Western Australian gold projects in the June 2025 quarter, balancing promising drill results with operational hurdles and a solid cash position.

Neurizon Therapeutics has secured a $1.5 million loan against its expected 2025 R&D tax rebate, boosting liquidity without diluting shareholders. This strategic move supports ongoing development of its neurodegenerative disease treatments.

Metals Australia reports a 595% surge in graphitic carbon intervals at its Lac Carheil project, advances critical infrastructure funding applications, and initiates copper-gold drilling at Warrego East.

Orange Minerals NL has raised $810,000 to fund exploration and due diligence on its new Tepa Gold Project acquisition in Ghana, while advancing promising Australian projects with notable assay results.

Novonix Limited reports significant progress in its synthetic graphite anode materials production, benefiting from new US tariffs on Chinese imports and strategic leadership appointments. The company also secures up to US$100 million in convertible debenture funding to support expansion plans.

GTi Energy has obtained critical drilling permits and contracted top Wyoming service providers to advance its Lo Herma uranium project, targeting a resource upgrade by year-end amid strong U.S. nuclear support.

ClearVue Technologies’ solar façade trial at Hong Kong EMSD headquarters reveals a rapid 2.6-year payback period with government incentives, alongside strong thermal and fire safety performance.

Imugene Limited has received a $5.87 million R&D tax refund, reinforcing its capacity to advance clinical trials in immuno-oncology. This funding milestone supports the development of its innovative cancer therapies, including CAR T cell treatments and oncolytic virotherapy.

ClearVue Technologies has secured $746,574 through a mix of equity and debt to support its international commercialisation efforts amid shifting market conditions.

Sprintex Limited has boosted its Türkiye presence by extending its exclusive distribution deal, securing a new A$377,000 order, and launching larger Jet Blowers aimed at industrial and municipal markets.